245 related articles for article (PubMed ID: 34097185)
1. Associations of Sleep Characteristics with Cerebrospinal Fluid sTREM2 in Cognitively Normal Older Adults: the CABLE Study.
Hu HY; Ma LZ; Hu H; Bi YL; Ma YH; Shen XN; Ou YN; Dong Q; Tan L; Yu JT
Neurotox Res; 2021 Aug; 39(4):1372-1380. PubMed ID: 34097185
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.
Ma LZ; Tan L; Bi YL; Shen XN; Xu W; Ma YH; Li HQ; Dong Q; Yu JT
Mol Neurodegener; 2020 Apr; 15(1):25. PubMed ID: 32276587
[TBL] [Abstract][Full Text] [Related]
3. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
Li TR; Lyu DY; Liu FQ;
J Alzheimers Dis; 2022; 90(3):1123-1138. PubMed ID: 36213998
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Heslegrave A; Heywood W; Paterson R; Magdalinou N; Svensson J; Johansson P; Öhrfelt A; Blennow K; Hardy J; Schott J; Mills K; Zetterberg H
Mol Neurodegener; 2016 Jan; 11():3. PubMed ID: 26754172
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification.
Knapskog AB; Henjum K; Idland AV; Eldholm RS; Persson K; Saltvedt I; Watne LO; Engedal K; Nilsson LNG
Sci Rep; 2020 Sep; 10(1):15886. PubMed ID: 32985583
[TBL] [Abstract][Full Text] [Related]
7. The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease.
Park SH; Lee EH; Kim HJ; Jo S; Lee S; Seo SW; Park HH; Koh SH; Lee JH
Sci Rep; 2021 Jun; 11(1):13050. PubMed ID: 34158530
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease.
Hok-A-Hin YS; Del Campo M; Boiten WA; Stoops E; Vanhooren M; Lemstra AW; van der Flier WM; Teunissen CE
J Neuroinflammation; 2023 May; 20(1):107. PubMed ID: 37147668
[TBL] [Abstract][Full Text] [Related]
9. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.
Franzmeier N; Suárez-Calvet M; Frontzkowski L; Moore A; Hohman TJ; Morenas-Rodriguez E; Nuscher B; Shaw L; Trojanowski JQ; Dichgans M; Kleinberger G; Haass C; Ewers M;
Mol Neurodegener; 2020 Oct; 15(1):57. PubMed ID: 33032659
[TBL] [Abstract][Full Text] [Related]
10. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.
Suárez-Calvet M; Kleinberger G; Araque Caballero MÁ; Brendel M; Rominger A; Alcolea D; Fortea J; Lleó A; Blesa R; Gispert JD; Sánchez-Valle R; Antonell A; Rami L; Molinuevo JL; Brosseron F; Traschütz A; Heneka MT; Struyfs H; Engelborghs S; Sleegers K; Van Broeckhoven C; Zetterberg H; Nellgård B; Blennow K; Crispin A; Ewers M; Haass C
EMBO Mol Med; 2016 May; 8(5):466-76. PubMed ID: 26941262
[TBL] [Abstract][Full Text] [Related]
11. Microglial Reactivity Correlates with Presynaptic Loss Independent of β-Amyloid and Tau.
Lan G; Chen X; Yang J; Sun P; Cai Y; Li A; Zhu Y; Liu Z; Ma S; Guo T;
Ann Neurol; 2024 May; 95(5):917-928. PubMed ID: 38356322
[TBL] [Abstract][Full Text] [Related]
12. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease.
Ewers M; Franzmeier N; Suárez-Calvet M; Morenas-Rodriguez E; Caballero MAA; Kleinberger G; Piccio L; Cruchaga C; Deming Y; Dichgans M; Trojanowski JQ; Shaw LM; Weiner MW; Haass C;
Sci Transl Med; 2019 Aug; 11(507):. PubMed ID: 31462511
[TBL] [Abstract][Full Text] [Related]
13. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
[TBL] [Abstract][Full Text] [Related]
14. CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.
Rauchmann BS; Schneider-Axmann T; Alexopoulos P; Perneczky R;
Neurobiol Aging; 2019 Feb; 74():182-190. PubMed ID: 30458365
[TBL] [Abstract][Full Text] [Related]
15. Sleep Characteristics and Cognitive Function in Older Adults Without Dementia: The CABLE Study.
Fu Y; Wang ZT; Qu Y; Wang XT; Ma YH; Bi YL; Dong Q; Tan L; Yu JT
J Alzheimers Dis; 2021; 84(3):1029-1038. PubMed ID: 34602483
[TBL] [Abstract][Full Text] [Related]
16. CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals.
Falcon C; Monté-Rubio GC; Grau-Rivera O; Suárez-Calvet M; Sánchez-Valle R; Rami L; Bosch B; Haass C; Gispert JD; Molinuevo JL
Neuroimage Clin; 2019; 23():101801. PubMed ID: 30978656
[TBL] [Abstract][Full Text] [Related]
17. CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.
Halaas NB; Henjum K; Blennow K; Dakhil S; Idland AV; Nilsson LN; Sederevicius D; Vidal-Piñeiro D; Walhovd KB; Wyller TB; Zetterberg H; Watne LO; Fjell AM
Cereb Cortex; 2020 Apr; 30(4):2295-2306. PubMed ID: 31812991
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
[TBL] [Abstract][Full Text] [Related]
19. Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.
Wu C; Ma YH; Hu H; Zhao B; Tan L;
J Alzheimers Dis; 2023; 92(1):311-322. PubMed ID: 36744335
[TBL] [Abstract][Full Text] [Related]
20. sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer's disease: The CABLE study.
Wang ZB; Sun Y; Ma YH; Fu Y; Hu H; Xu W; Wang ZT; Ma LZ; Tan L; Yu JT
Transl Psychiatry; 2022 Apr; 12(1):140. PubMed ID: 35379792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
